Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

Terminated

• Conditions: Stress Hyperglycemia; Diabetes Mellitus Type 2

• Registration Number: NCT02068989
• Lead Sponsor: Yale University

Brief Summary

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-02
• Study First Submitted: 2014-02-19
• Study First Submitted QC: 2014-02-19
• Study First Posted: 2014-02-21
• Primary Completion: 2015-03
• Study Completion: 2015-03
• Status Verified: 2016-09
• Last Update Submitted: 2016-09-02
• Last Update Posted: 2016-09-05

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

• All patients admitted to the intensive care unit at the Yale New Haven Hospital St. Raphael Campus and Norwalk Hospital

Read More

Exclusion Criteria

• Patients with prior history of diabetes mellitus
• Elevated admission HbA1c (≥6.5%)
• Age >80 years
• Metastatic disease with expected life expectancy of less than 12 months
• Pregnancy or a woman who plans to become pregnant

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Percentage of Subjects with an HbA1c greater than or equal to 6.5%	1 year

Trial Locations

Locations (2)

Norwalk Hospital; 🇺🇸 Norwalk, Connecticut, United States

Yale New Haven Hospital St. Raphael Campus; 🇺🇸 New Haven, Connecticut, United States